FIRMQUARRYResearch workspace

EU_TED process · buyer country ESP · award

Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg)

['Hospital Infantil Universitario Niño Jesús']

Procedure 71bdde95-33ad-4d2d-b705-6c2d1ef45212CPV 33600000Healthcare
EUR 115,385
Data last updated Oct 22, 2026 · Source: Tenders Electronic Daily
Buyer identifier
TED_ORGANISATION: Q2877003J
Primary supplier
['AMGEN, S.A.']
Procurement method
Not reported
Tender deadline
Not reported
Contract period
Not reported — Not reported
Native value
EUR 115,385
USD comparison
Not shown — no auditable FX observation
Official source
Open notice ↗

Description

Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg)

Suppliers

Official lifecycle

Process timeline

  1. Award announced

    Suministro de medicamento exclusivo Blinatumomab 38,5 microgramos inyectable (Blincyto 38,5 mcg)

    ESP · eu_tedEUR 115,385Source ↗

Notice versions

PublicationVersionTypeDateSource
755656-20261can-standardOct 30, 2026Official notice ↗ · XML ↗

Lots

LotCPVPerformanceNUTSValue
LOT-000133600000, 33600000ESPES300Not reported

Contracts

ContractLotStatusPeriodValue
A/SUM-017062/2026C01LOT-0001Not reportedNot reported — Not reportedNot reported

Auditable model output

Predictive intelligence

Predictive intelligenceInsufficient historyNo eligible point-in-time model has produced a prediction for this record.

Append-only source history

Source records

RecordDateStagesFetched
34eb299f-e354-41a5-ac3a-b31ecc0cb2fb:1Oct 30, 2026award_announcedOct 31, 2026